Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Mass treatment with single-dose azithromycin for trachoma.

Solomon AW, Holland MJ, Alexander ND, Massae PA, Aguirre A, Natividad-Sancho A, Molina S, Safari S, Shao JF, Courtright P, Peeling RW, West SK, Bailey RL, Foster A, Mabey DC.

N Engl J Med. 2004 Nov 4;351(19):1962-71.

2.

Antibiotics for trachoma.

Evans JR, Solomon AW.

Cochrane Database Syst Rev. 2011 Mar 16;(3):CD001860. doi: 10.1002/14651858.CD001860.pub3. Review.

PMID:
21412875
3.

Azithromycin for the treatment and control of trachoma.

Burton MJ, Frick KD, Bailey RL, Bowman RJ.

Expert Opin Pharmacother. 2002 Feb;3(2):113-20. Review.

PMID:
11829725
4.

Trachoma: a review.

Tabbara KF.

J Chemother. 2001 Apr;13 Suppl 1:18-22. Review.

PMID:
11434524
5.

Elimination of blinding trachoma.

Schachter J, Dawson CR.

Curr Opin Infect Dis. 2002 Oct;15(5):491-5. Review.

PMID:
12686881
6.

The effect of antibiotic treatment on active trachoma and ocular Chlamydia trachomatis infection.

Mabey D, Solomon A.

Expert Rev Anti Infect Ther. 2003 Aug;1(2):209-16. Review.

PMID:
15482115
7.

Trachoma and antibiotic use: the 'A' in SAFE.

West S.

Expert Rev Anti Infect Ther. 2012 Jan;10(1):75-83. doi: 10.1586/eri.11.150. Review.

PMID:
22149616
8.

Chlamydial infection during trachoma monitoring: are the most difficult-to-reach children more likely to be infected?

Keenan JD, Moncada J, Gebre T, Ayele B, Chen MC, Yu SN, Emerson PM, Stoller NE, McCulloch CE, Gaynor BD, Schachter J.

Trop Med Int Health. 2012 Mar;17(3):392-6. doi: 10.1111/j.1365-3156.2011.02919.x. Review.

9.

Review: Targeting trachoma: Strategies to reduce the leading infectious cause of blindness.

Baneke A.

Travel Med Infect Dis. 2012 Mar;10(2):92-6. doi: 10.1016/j.tmaid.2012.01.005. Review.

PMID:
22326056
10.

Trachoma.

Mabey DC, Solomon AW, Foster A.

Lancet. 2003 Jul 19;362(9379):223-9. Review.

PMID:
12885486
11.

Strategies to control trachoma.

Mathew AA, Turner A, Taylor HR.

Drugs. 2009 May 29;69(8):953-70. doi: 10.2165/00003495-200969080-00002. Review.

PMID:
19496626
12.

The added value of water, sanitation, and hygiene interventions to mass drug administration for reducing the prevalence of trachoma: a systematic review examining.

Travers A, Strasser S, Palmer SL, Stauber C.

J Environ Public Health. 2013;2013:682093. doi: 10.1155/2013/682093. Review.

13.

Modelling trachoma for control programmes.

Gambhir M, Basáñez MG, Blake IM, Grassly NC.

Adv Exp Med Biol. 2010;673:141-56. Review.

PMID:
20632535
14.

Trachoma: transmission, infection, and control.

Gambhir M, Basáñez MG, Turner F, Kumaresan J, Grassly NC.

Lancet Infect Dis. 2007 Jun;7(6):420-7. Review.

PMID:
17521595
15.

Trachoma: an update on prevention, diagnosis, and treatment.

Bhosai SJ, Bailey RL, Gaynor BD, Lietman TM.

Curr Opin Ophthalmol. 2012 Jul;23(4):288-95. doi: 10.1097/ICU.0b013e32835438fc. Review.

16.

Trachoma: recent developments.

Mabey D.

Adv Exp Med Biol. 2008;609:98-107. doi: 10.1007/978-0-387-73960-1_8. Review. No abstract available.

PMID:
18193660
17.

Trachoma: protective and pathogenic ocular immune responses to Chlamydia trachomatis.

Hu VH, Holland MJ, Burton MJ.

PLoS Negl Trop Dis. 2013;7(2):e2020. doi: 10.1371/journal.pntd.0002020. Review.

18.

[Prevalence of trachoma in the world].

Zhou YM, Sun XG.

Zhonghua Yan Ke Za Zhi. 2009 Sep;45(9):851-4. Review. Chinese.

PMID:
20137291
19.

Azithromycin 1.5% ophthalmic solution: in purulent bacterial or trachomatous conjunctivitis.

Garnock-Jones KP.

Drugs. 2012 Feb 12;72(3):361-73. doi: 10.2165/11208580-000000000-00000. Review.

PMID:
22316352
20.

Antibiotic Resistance in Streptococcus pneumoniae after Azithromycin Distribution for Trachoma.

Ho DK, Sawicki C, Grassly N.

J Trop Med. 2015;2015:917370. doi: 10.1155/2015/917370. Review.

Supplemental Content

Support Center